With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
An experimental vaccine — VSV-EBOV, produced by Merck — has helped to limit further spread. It had been administered to more than 126,000 individuals by the end of May, under a “ring vaccination” scheme in which it is being offered to frontline health workers and people who have come into contact with Ebola patients.
Pregnant and lactating women in the DRC finally have access to ... one of the best prevention tools we have against this deadly virus,” said Carleigh Krubiner, a faculty member at Johns Hopkins Berman Institute of Bioethics. “Hopefully this will set a new precedent for ongoing and future Ebola vaccination efforts, avoiding costly delays in protocol approvals while women face the very real threats of Ebola infection.”